March 27, 2023
A federal judge has dismissed a proposed class action against Johnson & Johnson over allegations that consumers were misled to believe "rapid release" Tylenol gelcaps work faster than less expensive options, saying there is no foreseeable risk of harm.
October 31, 2022
A Johnson & Johnson unit said Monday that "fatal Third Circuit law" dooms class claims brought in New Jersey federal court by California consumers alleging it falsely marketed its "rapid release" Tylenol gelcaps, brushing aside their attempt to apply Golden State law and Ninth Circuit precedent.
October 25, 2022
Golden State consumers have called on a New Jersey federal court to reject a Johnson & Johnson unit's bid to dismiss class claims alleging it falsely marketed its "rapid release" Tylenol gelcaps, saying the court should apply California law and Ninth Circuit precedent rather than the more restrictive Third Circuit authority cited by the company.
September 23, 2022
A Johnson & Johnson unit on Friday asked a New Jersey federal judge to toss a second attempt at a lawsuit from California consumers alleging that the company misled them to believe Tylenol Rapid Release Gelcaps work faster than tablets, saying they have no grounds to sue.
May 19, 2020
A Johnson & Johnson unit must face proposed class claims from California consumers that it misled them and others about how fast its "rapid release" Tylenol gelcaps work after a New Jersey federal judge on Tuesday rejected the company's argument that its statements were mere "puffery."